SEHA and the Israeli Khan Sagol Maccabi Institute for Research and Innovation are Cooperating to Promote Research Activities

Jerusalem, 13 July, 2022 (TPS) -- Abu Dhabi, July 13 / WAM – Emirates News Agency
The Abu Dhabi Health Services Company (SEHA), the largest healthcare network in the UAE, has signed , an agreement with the Khan Sagol Maccabi Institute for Research and Innovation of Maccabi Healthcare Services, the leading health management organization in Israel, with the aim of promoting joint medical research and technological innovation.

The Khan Sagol Maccabi Institute for Research and Innovation, under the agreement signed on June 29, 2022 at the headquarters of SEHA in the Emirate of Abu Dhabi, will provide the necessary support and infrastructure to conduct cooperative and coordinated activities in the areas of research, educational workshops, and the development of digital health technologies and innovation, relying on the expertise of the Khan Sagol Maccabi Institute.

The agreement will also contribute to supporting the emirate’s goals of building a registry for genome research to serve as a solid basis for improving clinical data management, sample collection and clinical report writing.

The partnership focuses on promoting medical research that combines big data capabilities and genetic and clinical research with the goal of advancing personalised medicine, while emphasising medical innovation and the establishment of a regional ecosystem that will support joint research activities. Studies will be conducted in cancer, cardiovascular disease, diabetes and more.

“This partnership supports SEHA’s vision and objectives of exploring collaboration opportunities in other areas that foster cooperation in education, research, health technology, and clinical programs. We look forward to a successful partnership and extending this program to our facilities and distinguished practitioners,” said SEHA Group CEO Saeed Al Kuwaiti.

Dr. Tal Patalon, Head of KSM, said, “We continue to build research collaborations with various countries in the region, implementing our vision of a shared innovative ecosystem that promotes research and development of advanced personalised medicine, while creating added value within the whole region.”

For his part, Dr. Ghanem Ali Al Hassani, Conference Chairman and SEHA’s Group Education and Research Director, said, “We are pleased to announce this signing with Kahn-Sagol-Maccabi, as the agreement will contribute to strengthening our cooperation in scientific research, genomic exploration and knowledge exchange to accelerate economic growth and human progress.”

Saeed Jaber Al-Kuwaiti, Group CEO of SEHA, said: “This agreement supports SEHA’s vision and objectives in exploring cooperation opportunities in other areas that enhance cooperation in education, research, health technology and clinical programs. We look forward to achieving success together and expanding this program to include our facilities and distinguished practitioners.”

Dr. Tal Batalon, President of the Khan Sagol Maccabi Institute of the Maccabi Research and Innovation Center added: “I am very excited to see this strategic collaboration between the Khan Sagol Maccabi Institute and SEHA. Let us chart our path together in building a bridge for joint research and providing support in developing a comprehensive ecosystem for the field of medical innovation. Through this partnership, we aim to enhance medical research and development activities in cooperation with SEHA in order to create new value for the entire region and ultimately the Middle East.”